Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. Puma is dedicated to advancing the treatment of HER2+ breast cancer and supporting women, their families, and the breast cancer community.
Further information about Puma Biotechnology may be found at www.pumabiotechnology.com
To learn about NERLYNX (neratinib) tablets, visit www.NERLYNX.com